{"id":"doi:10.1158/1078-0432.ccr-16-2554","kind":"article","title":"Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma","authors":["Zhong‐Yi Dong","Wen‐Zhao Zhong","Xu‐Chao Zhang","Jian Su","Zhi Xie","Si‐Yang Maggie Liu","Hai‐Yan Tu","Hua‐Jun Chen","Yue‐Li Sun","Qing Hua Zhou","Jin‐Ji Yang","Xue‐Ning Yang","Jiaxin Lin","Hong‐Hong Yan","Hao-Ran Zhai","Li‐Xu Yan","Ri-Qiang Liao","Si-Pei Wu","Yi-Long Lung Cancer Wu"],"author_count":19,"year":2016,"published":"2016-12-30","venue":"Clinical Cancer Research","cited_by":959,"doi":"10.1158/1078-0432.ccr-16-2554","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1158/1078-0432.ccr-16-2554","archive_url":"https://space-kitty.com/papers/doi:10.1158/1078-0432.ccr-16-2554","updated":null,"pmid":"28039262","pmcid":null,"openalex_id":"W2561459036","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}